| Literature DB >> 21529401 |
Brian D Foy1, Kevin C Kobylinski, Joy L Chilson Foy, Bradley J Blitvich, Amelia Travassos da Rosa, Andrew D Haddow, Robert S Lanciotti, Robert B Tesh.
Abstract
Clinical and serologic evidence indicate that 2 American scientists contracted Zika virus infections while working in Senegal in 2008. One of the scientists transmitted this arbovirus to his wife after his return home. Direct contact is implicated as the transmission route, most likely as a sexually transmitted infection.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21529401 PMCID: PMC3321795 DOI: 10.3201/eid1705.101939
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
FigureMaculopapular rash on patient 3 infected with Zika virus, Colorado, USA.
Serologic results for 3 patients in whom symptoms of arboviral illness developed, northern Colorado, USA, 2008*
| Serum sample | Viruses/viral antigens tested | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GETV | CHIKV | SINV | ZIKV | DENV1 | DENV2 | DENV3 | DENV4 | YFV | WNV | UGSV | SLEV | TAHV | JCV | LACV | |
| Hemagglutination inhibition test | |||||||||||||||
| Pt1a | 0 | 0 | NT | 5,120 | 2,560 | 640 | 2,560 | 2,560 | 5,120 | 2,560 | 1,280 | NT | 0 | NT | NT |
| Pt1c | 0 | 0 | NT | 5,120 | 1,280 | 320 | 1,280 | 1,280 | 2,560 | 1,280 | 1,280 | NT | 0 | NT | NT |
| Pt2a | 0 | 0 | NT | 1,280 | 160 | 80 | 320 | 320 | 1,280 | 160 | 160 | NT | 0 | NT | NT |
| Pt2c | 0 | 0 | NT | 2,560 | 160 | 80 | 320 | 320 | 1,280 | 160 | 160 | NT | 0 | NT | NT |
| Pt3a | 0 | 0 | NT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | NT | 0 | NT | NT |
| Pt3c | 0 | 0 | NT | 320 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | NT | 0 | NT | NT |
| Plaque-reduction neutralization test | |||||||||||||||
| Pt1a | NT | <10 | <10 |
| 80 |
| 320 | 160 |
| <10 | NT | 80 | <10 | NT | NT |
| Pt1c | NT | NT | NT |
| 160 | 230 | 320 | 320 |
| 160 | NT | NT | NT | NT | NT |
| Pt2a | NT | NT | NT |
| <20 | 80 | 80 | 40 |
| NT | NT | NT | NT | NT | NT |
| Pt2c | NT | NT | NT |
| 80 | 160 | 160 | 160 |
| 80 | NT | NT | NT | NT | NT |
| Pt3a | NT | NT | NT | 10 | <10 | <10 | <10 | <10 | <10 | <10 | NT | <10 | NT | <10 | <10 |
| Pt3c | NT | NT | NT |
| <10 | <10 | <10 | <10 | <10 | <10 | NT | NT | NT | NT | NT |
| Complement fixation test | |||||||||||||||
| Pt1a | NT | NT | NT | 64/8 | NT | NT | NT | NT | 64/8 | NT | NT | NT | NT | NT | NT |
| Pt1c | NT | NT | NT | 128/32 | NT | NT | NT | NT | 64/8 | NT | NT | NT | NT | NT | NT |
| Pt2a | NT | NT | NT | 16/8 | NT | NT | NT | NT | 16/8 | NT | NT | NT | NT | NT | NT |
| Pt2c | NT | NT | NT | 32/32 | NT | NT | NT | NT | 16/8 | NT | NT | NT | NT | NT | NT |
| Pt3a | NT | NT | NT | 0 | NT | NT | NT | NT | 0 | NT | NT | NT | NT | NT | NT |
| Pt3c | NT | NT | NT | 16/8 | NT | NT | NT | NT | 0 | NT | NT | NT | NT | NT | NT |
*Togaviridae: GETV, Getah virus; CHIKV, chikungunya virus; SINV, Sindbis virus; Flaviviridae: ZIK, Zika virus; DENV, dengue virus; YFV, yellow fever virus; WNV, West Nile virus; UGSV, Uganda S virus; SLEV, St. Louis encephalitis virus; Bunyaviridae: TAHV, Tahyna virus; JCV, Jamestown Canyon virus; LAC, La Crosse virus; pt1, 2, and 3, patients 1, 2, and 3, respectively; a and c, acute-phase and convalescent-phase serum samples, respectively; NT, not tested. Hemagglutination test, numbers are reciprocal of serum dilution inhibiting 4 units of antigen; 0 = negative reaction at a 1:20 dilution. Plaque-reduction neutralization test, numbers refer to neutralizing antibody titers with a 90% cutoff value: titers > positive control serum samples are indicated in boldface. Complement fixation tests, numbers refer to reciprocal of serum titer/reciprocal of antigen titer; 0, negative reaction at <8/<8.